Alpha 2.0
Login Register
» Articles » PMID: 27201337

Cost Consequence Analysis Of Darbepoetin Alfa For The Treatment Of Anemia Due To Chronic Kidney Disease (Ckd) In Greece

Overview
Journal Value Health
Publisher Elsevier
Specialties Biomedical Engineering
Pharmacology
Public Health
Date 2016 May 21
PMID 27201337
Citations 2
Authors
G Kourlaba
I Boletis
D Goumenos
C Iatrou
V Papagiannopoulou
G Tritaki
N Maniadakis
Affiliations
Soon will be listed here.
Citing Articles

Short versus long-acting erythropoiesis-stimulating agents for anemia management in Egyptian hemodialysis patients.

Soliman A, Magdy S, Ayoub H, Ebid A Qatar Med J. 2024; 2024(1):16.

PMID: 38567102 PMC: 10985414. DOI: 10.5339/qmj.2024.16.

Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail.

Chen N, Xing C, Niu J, Liu B, Fu J, Zhao J Chronic Dis Transl Med. 2022; 8(1):59-70.

PMID: 35620165 PMC: 9128564. DOI: 10.1002/cdt3.13.